Patent · US Active

Oncolytic adenoviruses armed with heterologous genes

US11439678B2 · kind B2 · utility

1Cited by
16References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2018
Grant dateSep 13, 2022
Priority date—
Expiry dateApr 21, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/10343
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to a group B adenovirus comprising a sequence of formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.